(RTTNews) - Monday, Pharming Group NV (PHARM.PK) said it appointed Sijmen de Vries as chief executive officer of the company, effective November 3. Vries will succeed Francis Pinto, who will retire at the next Annual General Meeting of Shareholders

Pharming Shareholders appoint Sijmen de Vries as new CEO - MSN MoneyCentral
Leiden, The Netherlands, October 13, 2008. Biotech company Pharming Group NV (”Pharming” or “The Company”) (Euronext: PHARM) announced today the appointment of Dr Sijmen de Vries as Chief Executive Officer (CEO) of Pharming. This decision was taken

Trusteer Adds Protection Against SilentBanker and Other Malware that - Forbes
Trusteer, the customer protection company for online businesses, today announced that it has enhanced its Rapport product to prevent user-space malware patches from taking control of a web session after a user has logged-on to a secure web site using

Pharming Group N.V. (NL) - Pharming Announces Third Quarter 2008 - Phramalive.com
Significant progress with lead product Rhucin Leiden, The Netherlands, October 17, 2008. Biotech company Pharming Group NV (”Pharming” or “the Company”) (NYSE Euronext: PHARM) announced today its results for the first nine months of 2008 ended

Pharming Announces Third Quarter 2008 Results - WebWire
Significant progress with lead product Rhucin Leiden, The Netherlands. Biotech company Pharming Group NV ( Pharming or the Company ) (NYSE Euronext: PHARM) announced today its results for the first nine months of 2008 ended September 30

Pharming Group names new CEO - Pharmaceutical Business Review
Dr de Vries joins Pharming from Swiss-based 4-Antibody where he was CEO. Dr de Vries has also been CEO of Morphochem and prior to this spent many years at Novartis and at SmithKline Beecham Pharmaceuticals where he held senior business and commercial

Tags: